Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The Hippo pathway is a highly dynamic cellular signaling nexus that plays central roles in multiple cell types and regulates regeneration, metabolism, and development. The Hippo pathway integrates mechanotransduction, cell polarity, inflammation, and numerous types of paracrine signaling. If not tightly regulated, dysregulated Hippo pathway signaling drives the onset and progression of a range of diseases, including fibrosis and cancer. The molecular understanding of the Hippo pathway is rapidly evolving. This Special Issue contains ten articles contributed by established and up-and-coming Hippo pathway experts that, as a whole, provides an up-to-date overview of how dysregulated Hippo pathway activity is a common driver of specific diseases. The articles have a particular focus on the underlying molecular and cellular mechanisms that cause the Hippo pathway to go awry, and especially how this drives disease. The articles analyze disease-specific as well as common themes, which provides valuable insights into the fundamental molecular mechanisms in the dysfunctioning Hippo pathway, and thereby offer practical insights into potential future therapeutic intervention strategies.

STRIPAK --- skin cancer --- n/a --- Lats2 --- transcription --- myofibroblast --- epigenetic --- Hippo --- cancer immunity --- TAZ --- Taz --- TAZ (transcriptional co-activator with PDZ-binding motif) --- adaptive immunity --- fibroblasts --- innate immunity --- LATS --- MST (mammalian STE20-like protein kinase) --- phosphorylation --- stem cells --- wound healing --- signal transduction --- angiogenesis --- LATS1/2 --- EMT --- protein-protein interactions --- structure biology --- Hippo pathway --- hippo pathway --- autoimmunity --- Mps one binder --- YAP/TAZ --- GPCR --- fibrosis --- MST1/2 --- YAP (yes-associated protein) --- YAP --- Yap --- protein kinase --- LATS (large tumor suppressor kinase) --- peripheral nerve sheath tumor --- signal cross-talk --- stem cell --- skin development --- STK38 --- tumorigenesis --- NDR --- schwannoma --- G protein-coupled receptor --- anti-cancer therapy --- feedback loops --- vascular mimicry --- castration resistance --- chromatin --- Hippo signalling --- ECM --- MST --- prostate cancer --- TEAD --- cancer --- zebrafish

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

There is unequivocal experimental, epidemiological, and clinical evidence demonstrating a correlation between diet and increased risk of cardiovascular disease (CVD). While nutritionally-poor diets can have a significant negative impact on cardiovascular health, dietary interventions with specific nutrients and/or functional foods are considered cost-effective and efficient components of prevention strategies. It has been estimated that nutritional factors may be responsible for approximately 40% of all CVD. Indeed, in one of the seminal studies conducted on modifiable risk factors and heart health (the INTERHEART study), >90% of all myocardial infarctions were attributed to preventable environmental factors with nutrition identified as one of the important determinants of CVD. There is an increasing public interest in and scientific investigation into establishing dietary approaches that can be undertaken for the prevention and treatment of CVD. This Special Issue provides an insight into the influential role of nutrition and dietary habits on cardiovascular health and disease, as well as their mechanisms of therapeutic and preventive action.

magnesium deficiency --- arterial hypertension --- vascular tone --- arterial stiffness --- vascular remodeling --- insulin resistance --- magnesium supplementation --- dietary magnesium intake --- Zeb2 --- cardiac fibroblast --- activated myofibroblast --- cardiac fibrosis --- fibroblast contractility --- fish oil --- omega-3 fatty acids --- eicosapentaenoic acid (EPA) --- docosahexaenoic acid (DHA) --- cardiovascular disease --- irisin --- pediatric --- children --- nutrition --- diet --- body composition --- metabolic syndrome --- obesity, neonates --- Mediterranean diet --- inflammation --- nutrients --- polyphenols --- MUFA --- PUFA --- bioactive compounds --- phytosterols --- dietary pattern --- Aronia melanocarpa --- standardized extract --- dietary strategies --- supplementation --- cocaine --- cardiovascular health --- heart disease --- acute effects --- chronic effects --- marinobufagenin --- ouabain --- salt --- hypertension --- fibrosis --- Panax quinquefolius --- ginseng berry --- myocardial infarction --- phenolic compounds --- vascular aging --- vascular calcification --- arteriosclerosis --- Klotho --- chronic kidney disease (CKD), cancer --- diabetes --- heart failure --- micronutrients --- iron --- vitamins --- trace elements --- vitamin D --- seasonal variation --- lifestyle --- cytokines --- lipids --- mechanisms --- immunoregulatory --- eicosapentaenoic acid --- docosahexaenoic acid --- omega-3 polyunsaturated fatty acids --- coronary heart disease --- stretching --- TGF-β1 --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

There is unequivocal experimental, epidemiological, and clinical evidence demonstrating a correlation between diet and increased risk of cardiovascular disease (CVD). While nutritionally-poor diets can have a significant negative impact on cardiovascular health, dietary interventions with specific nutrients and/or functional foods are considered cost-effective and efficient components of prevention strategies. It has been estimated that nutritional factors may be responsible for approximately 40% of all CVD. Indeed, in one of the seminal studies conducted on modifiable risk factors and heart health (the INTERHEART study), >90% of all myocardial infarctions were attributed to preventable environmental factors with nutrition identified as one of the important determinants of CVD. There is an increasing public interest in and scientific investigation into establishing dietary approaches that can be undertaken for the prevention and treatment of CVD. This Special Issue provides an insight into the influential role of nutrition and dietary habits on cardiovascular health and disease, as well as their mechanisms of therapeutic and preventive action.

Research & information: general --- Biology, life sciences --- Food & society --- magnesium deficiency --- arterial hypertension --- vascular tone --- arterial stiffness --- vascular remodeling --- insulin resistance --- magnesium supplementation --- dietary magnesium intake --- Zeb2 --- cardiac fibroblast --- activated myofibroblast --- cardiac fibrosis --- fibroblast contractility --- fish oil --- omega-3 fatty acids --- eicosapentaenoic acid (EPA) --- docosahexaenoic acid (DHA) --- cardiovascular disease --- irisin --- pediatric --- children --- nutrition --- diet --- body composition --- metabolic syndrome --- obesity, neonates --- Mediterranean diet --- inflammation --- nutrients --- polyphenols --- MUFA --- PUFA --- bioactive compounds --- phytosterols --- dietary pattern --- Aronia melanocarpa --- standardized extract --- dietary strategies --- supplementation --- cocaine --- cardiovascular health --- heart disease --- acute effects --- chronic effects --- marinobufagenin --- ouabain --- salt --- hypertension --- fibrosis --- Panax quinquefolius --- ginseng berry --- myocardial infarction --- phenolic compounds --- vascular aging --- vascular calcification --- arteriosclerosis --- Klotho --- chronic kidney disease (CKD), cancer --- diabetes --- heart failure --- micronutrients --- iron --- vitamins --- trace elements --- vitamin D --- seasonal variation --- lifestyle --- cytokines --- lipids --- mechanisms --- immunoregulatory --- eicosapentaenoic acid --- docosahexaenoic acid --- omega-3 polyunsaturated fatty acids --- coronary heart disease --- stretching --- TGF-β1 --- magnesium deficiency --- arterial hypertension --- vascular tone --- arterial stiffness --- vascular remodeling --- insulin resistance --- magnesium supplementation --- dietary magnesium intake --- Zeb2 --- cardiac fibroblast --- activated myofibroblast --- cardiac fibrosis --- fibroblast contractility --- fish oil --- omega-3 fatty acids --- eicosapentaenoic acid (EPA) --- docosahexaenoic acid (DHA) --- cardiovascular disease --- irisin --- pediatric --- children --- nutrition --- diet --- body composition --- metabolic syndrome --- obesity, neonates --- Mediterranean diet --- inflammation --- nutrients --- polyphenols --- MUFA --- PUFA --- bioactive compounds --- phytosterols --- dietary pattern --- Aronia melanocarpa --- standardized extract --- dietary strategies --- supplementation --- cocaine --- cardiovascular health --- heart disease --- acute effects --- chronic effects --- marinobufagenin --- ouabain --- salt --- hypertension --- fibrosis --- Panax quinquefolius --- ginseng berry --- myocardial infarction --- phenolic compounds --- vascular aging --- vascular calcification --- arteriosclerosis --- Klotho --- chronic kidney disease (CKD), cancer --- diabetes --- heart failure --- micronutrients --- iron --- vitamins --- trace elements --- vitamin D --- seasonal variation --- lifestyle --- cytokines --- lipids --- mechanisms --- immunoregulatory --- eicosapentaenoic acid --- docosahexaenoic acid --- omega-3 polyunsaturated fatty acids --- coronary heart disease --- stretching --- TGF-β1

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Acute kidney injury (AKI) is still associated with high morbidity and mortality incidence rates, and also bears an elevated risk of subsequent chronic kidney disease. Although the kidney has a remarkable capacity for regeneration after injury and may recover completely depending on the type of renal lesions, the options for clinical intervention are restricted to fluid management and extracorporeal kidney support. The development of novel therapies to prevent AKI, to improve renal regeneration capacity after AKI, and to preserve renal function is urgently needed. The Special Issue covers research articles that investigated the molecular mechanisms of inflammation and injury during different renal pathologies, renal regeneration, diagnostics using new biomarkers, and the effects of different stimuli like medication or bacterial components on isolated renal cells or in vivo models. The Special Issue contains important reviews that consider the current knowledge of cell death and regeneration, inflammation, and the molecular mechanisms of kidney diseases. In addition, the potential of cell-based therapy approaches that use mesenchymal stromal/stem cells or their derivates is summarized. This edition is complemented by reviews that deal with the current data situation on other specific topics like diabetes and diabetic nephropathy or new therapeutic targets.

microRNAs --- n/a --- transcription --- ischemia/reperfusion injury --- DSS-colitis --- kidney inflammation --- therapeutics targets --- CXCL13 --- glomerulus --- interleukin-6 --- rhabdomyolysis --- IgA nephropathy --- CREB Regulated Transcriptional Coactivators (CRTC) --- slit diaphragm --- injury --- xanthine oxidase --- Salt Inducible Kinase (SIK) --- acute and chronic kidney disease --- therapeutic target --- KIT-IgA score --- G-protein-coupled bile acid receptor (TGR5) --- lysophosphatidic acid --- glomerular injury --- IL-18 --- mesenchymal stem cells --- Taiwan --- acute kidney injury --- renal ischemia-reperfusion --- long non-coding RNA --- fibrosis --- acute kidney failure --- diabetic kidney diseases --- chronic kidney disease --- lncRNA --- LPS-binding protein --- endotoxemia-induced oliguric kidney injury --- dapagliflozin --- cPLA2 and COX-2 --- NLRP3 inflammasome --- CmklR1 --- haem --- chronic kidney injury --- omega-3 fatty acid --- noninvasive --- inflammation --- regulated necrosis --- GLP-1 receptor agonists --- miRNA --- AKI --- SGLT2 inhibitors --- diabetic kidney disease --- extracellular vesicles --- podocin --- type IV collagen --- epithelial cells --- nephrin --- 2-kidney-1-clip --- renal fibrosis --- papilla --- diagnostics --- necrosis --- non-coding RNAs --- podocyte --- Thy1.1 nephritis --- KIT assay --- oxidative stress --- conditioned medium --- C-reactive protein --- pericyte --- myofibroblast --- Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-?B) --- endotoxemia --- modifier gene --- polymorphism --- renal stem cells --- kidney --- polyploidization --- Class IIa Histone Deacetylases (HDAC) --- 2k1c --- molecular signaling --- proximal tubule --- arachidonic acid --- empagliflozin --- tubular injury --- signaling cascade --- signal transduction --- inflammatory maker --- niches --- biomarkers --- renal progenitors --- type V collagen --- cyclooxygenase --- focal segmental glomerulosclerosis --- inflammatory bowel disease (IBD) --- chronic kidney disease (CKD) --- allograft rejection --- renovascular hypertension --- genotype --- molecular mechanisms --- ROS --- prediction --- glomerular filtration barrier (GFB) --- alport syndrome --- scattered tubular cells --- long non-coding RNAs --- renal inflammation --- lysophosphatidic acid receptor --- cAMP Regulatory Element Binding Protein (CREB) --- Farnesiferol B --- differentiation --- mesenchymal stromal cells --- modified-MSCs --- kidney transplantation --- polyunsaturated fatty acids --- apoptosis --- type I collagen --- diabetes mellitus --- natural products --- lipoxygenase --- stem cell --- T cell-mediated rejection --- exosomes --- renal injury --- obese kidney fibrosis --- kidney injury --- cytotoxicity --- mesenchymal stem cell --- pigment nephropathy --- mesodermal stem cell --- ischemia-reperfusion --- cytochrome P450 --- renal cell carcinoma --- hematuria --- B-cell attracting chemokine --- microRNA --- chemerin --- glomerular basement membrane --- glomerular damage --- renal tubular cells --- kidney proximal tubule --- exosome --- hypertension --- diabetic nephropathy